Search research articles
Contact Us
Filters
Showing results (111-120 of 138) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2011
Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer
Dan Li, Yulan Zhao, Changxing Liu, et al.
Research Square
|
April 17, 2023
Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy
Lubna Naaz Chaudhary, Julie Jorns, Yunguang Sun, et al.
EMBO Molecular Medicine
|
February 1, 2014
Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury
Sabyasachi Bhattacharya, Kanstantsin V Katlinski, Maximilian Reichert, et al.
Molecular Cancer Research : MCR
|
November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer Cells
Noreen McBrearty, Christina Cho, Jinyun Chen, et al.
Cancer Research
|
August 12, 2021
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
Anjali Geethadevi, Ajay Nair, Deepak Parashar, et al.
Cell Reports
|
November 3, 2021
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
Jasmine George, Yongsheng Li, Ishaque P Kadamberi, et al.
Cancer Research
|
July 31, 2025
Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells
Signe Caksa, Timothy J Purwin, Dan A Erkes, et al.
Cell Reports
|
March 8, 2023
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
Jasmine George, Yongsheng Li, Ishaque P Kadamberi, et al.
The Journal of Clinical Investigation
|
May 17, 2021
Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapies
Zhen Lu, Angelica Ortiz, Ioannis I Verginadis, et al.
Breast Cancer Research and Treatment
|
June 6, 2019
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome
Cody Plasterer, Shirng-Wern Tsaih, Amy R Peck, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 138) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 26, 2011
Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer
Dan Li, Yulan Zhao, Changxing Liu, et al.
Research Square
|
April 17, 2023
Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy
Lubna Naaz Chaudhary, Julie Jorns, Yunguang Sun, et al.
EMBO Molecular Medicine
|
February 1, 2014
Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury
Sabyasachi Bhattacharya, Kanstantsin V Katlinski, Maximilian Reichert, et al.
Molecular Cancer Research : MCR
|
November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer Cells
Noreen McBrearty, Christina Cho, Jinyun Chen, et al.
Cancer Research
|
August 12, 2021
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth
Anjali Geethadevi, Ajay Nair, Deepak Parashar, et al.
Cell Reports
|
November 3, 2021
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
Jasmine George, Yongsheng Li, Ishaque P Kadamberi, et al.
Cancer Research
|
July 31, 2025
Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells
Signe Caksa, Timothy J Purwin, Dan A Erkes, et al.
Cell Reports
|
March 8, 2023
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
Jasmine George, Yongsheng Li, Ishaque P Kadamberi, et al.
The Journal of Clinical Investigation
|
May 17, 2021
Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapies
Zhen Lu, Angelica Ortiz, Ioannis I Verginadis, et al.
Breast Cancer Research and Treatment
|
June 6, 2019
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome
Cody Plasterer, Shirng-Wern Tsaih, Amy R Peck, et al.
Page
of 14